Header Logo

Connection

MARTIN KORBLING to Patient Selection

Back to Details
This is a "connection" page, showing publications MARTIN KORBLING has written about Patient Selection.
MARTIN KORBLING
Connection Strength
0.009
Patient Selection
  1. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood. 2004 Aug 01; 104(3):857-64.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.